UPDATE: Guggenheim Starts Legand Biotech Corp. (LEGN) at Neutral
Tweet Send to a Friend
(Updated - October 31, 2022 6:49 AM EDT)
Guggenheim analyst Kelsey Goodwin initiates coverage on Legand Biotech Corp. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggenheim analyst Kelsey Goodwin initiates coverage on Legand Biotech Corp. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
